Loopbaan van Kamalam Unninayar
Eerdere bekende functies van Kamalam Unninayar
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| HARVARD BIOSCIENCE, INC. | Financieel Directeur/CFO | 26-11-2018 | 31-05-2019 |
| TETRAPHASE PHARMACEUTICALS, INC. | Financieel Directeur/CFO | 16-10-2017 | 16-03-2018 |
Opleiding van Kamalam Unninayar
| Wichita State University | Graduate Degree |
| University of Delhi | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| India | 2 |
Operationeel
| Director of Finance/CFO | 2 |
| Graduate Degree | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| HARVARD BIOSCIENCE, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
- Beurs
- Insiders
- Kamalam Unninayar
- Ervaring
